Invention Application
US20100178333A1 SUSTAINED RELEASE DOSAGE FORM OF PHENOTHIAZINE DERIVATIVES CONTAINING CHANNELIZER
审中-公开
含有通道的苯并噻嗪衍生物的持续释放剂量形式
- Patent Title: SUSTAINED RELEASE DOSAGE FORM OF PHENOTHIAZINE DERIVATIVES CONTAINING CHANNELIZER
- Patent Title (中): 含有通道的苯并噻嗪衍生物的持续释放剂量形式
-
Application No.: US12063812Application Date: 2007-01-23
-
Publication No.: US20100178333A1Publication Date: 2010-07-15
- Inventor: Jayanta Kumar Mandal , Nitesh Nalinchandra Pandya , Kirti Bansidhar Maheshwari
- Applicant: Jayanta Kumar Mandal , Nitesh Nalinchandra Pandya , Kirti Bansidhar Maheshwari
- Applicant Address: IN Ahmedabad, Gujarat
- Assignee: ASTRON RESEARCH LIMITED
- Current Assignee: ASTRON RESEARCH LIMITED
- Current Assignee Address: IN Ahmedabad, Gujarat
- Priority: IN124/MUM/2006 20060125
- International Application: PCT/IN07/00031 WO 20070123
- Main IPC: A61K9/52
- IPC: A61K9/52 ; A61K9/14 ; A61K9/22 ; A61K31/554 ; A61P25/18
Abstract:
Once a day sustained release solid oral dosage form of phenothiazine derivative preferably the dibenzothiazepine derivative and their pharmaceutically acceptable salts comprising of a channelizer, rate controlling polymer and suitable pharmaceutically acceptable excipients. The formulation of the present invention is in the form of tablet or capsule which provides a sustained drug action upto 24 hours upon single dose administration.
Information query
